Frist Cressey Ventures

Frist Cressey Ventures, established in 2016 and headquartered in Nashville, Tennessee, is a venture capital firm specializing in early and growth-stage healthcare companies. It invests in technology and service businesses that enhance care quality, system integration, patient outcomes, and population health. The firm partners with entrepreneurs who share its core values, aiming to accelerate growth and improve healthcare through value-added collaborations.

Tommaso Auerbach

Investment Associate

Olivia Capra

Principal

Chloe Coulter

Senior Associate

Navid Farzad

Managing Partner

Matt Schappell

Principal

Mark Tipps

Partner and COO

William Trapnell

Senior Associate

Lydia Witty

Investment Associate

Caroline Young

Vice President

Past deals in Health Care

Bicycle Health

Venture Round in 2025
Bicycle Health is a virtual addiction medicine clinic focused on treating opioid dependence and use disorder. Established in 2017 in San Francisco, California, the company offers a telemedicine platform that connects patients with addiction medicine specialists for medical evaluations and follow-ups via phone and video calls. Patients can book appointments and receive electronic prescriptions that are sent to nearby pharmacies, with medications delivered directly to their homes. Bicycle Health collaborates with patients' insurance providers to facilitate reimbursement for services, positioning itself as a valuable resource for physicians and their patients while enhancing the patient-provider relationship.

Qualified Health

Seed Round in 2025
Qualified Health is a technology company specializing in generative artificial intelligence (AI) for healthcare. It provides an infrastructure solution that ensures safe and effective use of AI in medicine, offering features such as continuous algorithm performance monitoring, active AI governance, and customizable AI agents tailored to healthcare needs. The company partners with leading health systems in the U.S. to revolutionize healthcare through AI.

Thyme Care

Series C in 2024
Thyme Care is a healthcare company focused on providing comprehensive oncology care management services. It partners with health plans to deliver an integrated oncology solution that emphasizes whole-person care for cancer patients. By employing a tech-enabled platform, Thyme Care offers personalized support through physician-guided oncology nurses and resource specialists who educate and guide patients throughout their cancer journey. This model generates actionable insights that help healthcare providers identify at-risk patients earlier, facilitating timely access to quality resources and care. Thyme Care aims to enhance the cancer experience through early and ongoing intervention, ensuring that every cancer patient receives the individualized care they need.

Praia Health

Series A in 2024
Praia Health is a technology company that specializes in digital health solutions for hospitals. Its platform aims to enhance patient care by creating personalized health journeys, connecting patients to relevant services and resources, and providing hospitals with comprehensive patient profiles that extend beyond clinical records. This enables healthcare providers to offer more tailored and specialized care throughout the patient's health journey, fostering stronger patient relationships.

Thyme Care

Series B in 2023
Thyme Care is a healthcare company focused on providing comprehensive oncology care management services. It partners with health plans to deliver an integrated oncology solution that emphasizes whole-person care for cancer patients. By employing a tech-enabled platform, Thyme Care offers personalized support through physician-guided oncology nurses and resource specialists who educate and guide patients throughout their cancer journey. This model generates actionable insights that help healthcare providers identify at-risk patients earlier, facilitating timely access to quality resources and care. Thyme Care aims to enhance the cancer experience through early and ongoing intervention, ensuring that every cancer patient receives the individualized care they need.

DexCare

Series C in 2023
DexCare is a Seattle-based company founded in 2021 that specializes in providing a platform-as-a-service solution for managing health system capacity and demand across various lines of care. The company's platform aims to transform traditional patient-to-provider relationships into scalable digital experiences, thereby increasing revenue from new patients while reducing acquisition costs. By optimizing access to healthcare services, DexCare helps healthcare institutions generate new patients, enhance satisfaction, achieve cost savings, and ensure that patients receive timely and effective care.

Memora Health

Venture Round in 2023
Memora Health Inc., founded in 2016 and based in San Francisco, California, develops an enterprise healthcare productivity platform aimed at automating outpatient communication and enhancing care delivery. The company partners with health systems, health plans, and digital health organizations to streamline clinical workflows, allowing clinicians to focus on their primary responsibilities while proactively engaging patients throughout their care journeys. Memora's platform digitizes high-touch processes, intelligently triaging patient-reported data to the relevant care team members and facilitating proactive, two-way communication between patients and providers. By transforming the way care is delivered, Memora Health seeks to make healthcare more actionable, accessible, and continuous.

Monogram Health

Series C in 2023
Monogram Health, Inc. is a provider of kidney care services based in Nashville, Tennessee, specializing in the management of chronic kidney disease and end-stage renal disease. Established in 2019, the company employs an innovative in-home care delivery model that integrates evidence-based clinical services, including complex case and disease management, utilization management, and medication therapy management. Monogram Health focuses on improving patient outcomes and quality of life while reducing medical costs through predictive analysis and next-generation artificial intelligence algorithms. It collaborates with leading health plans and risk-bearing providers to deliver care across various insurance products in 34 states, aiming to enhance the management of patients with polychronic conditions and ensure seamless transitions to dialysis and pre-emptive kidney transplants.

Carta Healthcare

Series B in 2022
Carta Healthcare, Inc. is a technology company that specializes in developing a software-as-a-service platform aimed at improving hospital patient management. Founded in 2016 and headquartered in San Mateo, California, the company leverages data from existing IT systems to map the patient journey through hospitals. Its platform utilizes machine learning to identify similarities between current patients and past patients, allowing healthcare providers to personalize care based on individual needs. Additionally, it predicts potential bottlenecks, such as recovery bed shortages and cancellations, offering alerts that help hospitals optimize their operations. By combining artificial intelligence with human expertise, Carta Healthcare enhances the efficiency and quality of healthcare data management, ultimately aiming to provide a better experience for patients.

Hint Health

Series B in 2022
Hint Health Inc. is a San Francisco-based company that specializes in developing a membership management platform tailored for direct care providers. Founded in 2013 by Zak Holdsworth and Graham Melcher, Hint Health offers tools that facilitate membership administration and billing, enabling healthcare providers to operate and manage their own plans effectively. This platform supports a range of offerings, including essential, plus, pro, and enterprise plans, allowing organizations to design and implement direct primary care programs. By empowering providers to compete directly with traditional insurance models, Hint Health aims to transform the healthcare system, enhancing cost efficiency, quality of care, and patient outcomes. The company also hosts the Hint Summit, a conference that gathers healthcare professionals and industry leaders to discuss and promote healthcare reform in the United States.

Bicycle Health

Series B in 2022
Bicycle Health is a virtual addiction medicine clinic focused on treating opioid dependence and use disorder. Established in 2017 in San Francisco, California, the company offers a telemedicine platform that connects patients with addiction medicine specialists for medical evaluations and follow-ups via phone and video calls. Patients can book appointments and receive electronic prescriptions that are sent to nearby pharmacies, with medications delivered directly to their homes. Bicycle Health collaborates with patients' insurance providers to facilitate reimbursement for services, positioning itself as a valuable resource for physicians and their patients while enhancing the patient-provider relationship.

Memora Health

Venture Round in 2022
Memora Health Inc., founded in 2016 and based in San Francisco, California, develops an enterprise healthcare productivity platform aimed at automating outpatient communication and enhancing care delivery. The company partners with health systems, health plans, and digital health organizations to streamline clinical workflows, allowing clinicians to focus on their primary responsibilities while proactively engaging patients throughout their care journeys. Memora's platform digitizes high-touch processes, intelligently triaging patient-reported data to the relevant care team members and facilitating proactive, two-way communication between patients and providers. By transforming the way care is delivered, Memora Health seeks to make healthcare more actionable, accessible, and continuous.

DexCare

Series B in 2022
DexCare is a Seattle-based company founded in 2021 that specializes in providing a platform-as-a-service solution for managing health system capacity and demand across various lines of care. The company's platform aims to transform traditional patient-to-provider relationships into scalable digital experiences, thereby increasing revenue from new patients while reducing acquisition costs. By optimizing access to healthcare services, DexCare helps healthcare institutions generate new patients, enhance satisfaction, achieve cost savings, and ensure that patients receive timely and effective care.

Thyme Care

Series A in 2021
Thyme Care is a healthcare company focused on providing comprehensive oncology care management services. It partners with health plans to deliver an integrated oncology solution that emphasizes whole-person care for cancer patients. By employing a tech-enabled platform, Thyme Care offers personalized support through physician-guided oncology nurses and resource specialists who educate and guide patients throughout their cancer journey. This model generates actionable insights that help healthcare providers identify at-risk patients earlier, facilitating timely access to quality resources and care. Thyme Care aims to enhance the cancer experience through early and ongoing intervention, ensuring that every cancer patient receives the individualized care they need.

Monogram Health

Series B in 2021
Monogram Health, Inc. is a provider of kidney care services based in Nashville, Tennessee, specializing in the management of chronic kidney disease and end-stage renal disease. Established in 2019, the company employs an innovative in-home care delivery model that integrates evidence-based clinical services, including complex case and disease management, utilization management, and medication therapy management. Monogram Health focuses on improving patient outcomes and quality of life while reducing medical costs through predictive analysis and next-generation artificial intelligence algorithms. It collaborates with leading health plans and risk-bearing providers to deliver care across various insurance products in 34 states, aiming to enhance the management of patients with polychronic conditions and ensure seamless transitions to dialysis and pre-emptive kidney transplants.

Vim

Series B in 2021
Vim, Inc. is a healthcare technology company founded in 2015 and based in San Francisco, California. The company develops a platform that enhances the connection between patients and healthcare providers by offering online services for finding, scheduling, and receiving care. Its solutions include online booking and referral coordination, facilitating seamless communication and data sharing among health plans, patients, and a wide range of medical providers, from independent practitioners to large healthcare systems. Vim's platform integrates with electronic health records, enabling real-time access to patient data and insights at the point of care. By improving connectivity within clinical operations, Vim aims to support the delivery of affordable, high-quality healthcare.

DexCare

Series A in 2021
DexCare is a Seattle-based company founded in 2021 that specializes in providing a platform-as-a-service solution for managing health system capacity and demand across various lines of care. The company's platform aims to transform traditional patient-to-provider relationships into scalable digital experiences, thereby increasing revenue from new patients while reducing acquisition costs. By optimizing access to healthcare services, DexCare helps healthcare institutions generate new patients, enhance satisfaction, achieve cost savings, and ensure that patients receive timely and effective care.

Klara

Series A in 2020
Klara operates an end-to-end patient engagement platform tailored for healthcare organizations, facilitating efficient communication between practitioners and patients. The platform allows healthcare teams to provide virtual care, collaborate internally, and automate various front-desk tasks, streamlining workflows and enhancing the patient experience throughout the care journey. Used by thousands of healthcare teams across over 40 specialties, Klara aims to improve operational efficiency and support the growth of patient volume while ensuring easy access to practices and centralized management of administrative responsibilities.

Monogram Health

Series A in 2020
Monogram Health, Inc. is a provider of kidney care services based in Nashville, Tennessee, specializing in the management of chronic kidney disease and end-stage renal disease. Established in 2019, the company employs an innovative in-home care delivery model that integrates evidence-based clinical services, including complex case and disease management, utilization management, and medication therapy management. Monogram Health focuses on improving patient outcomes and quality of life while reducing medical costs through predictive analysis and next-generation artificial intelligence algorithms. It collaborates with leading health plans and risk-bearing providers to deliver care across various insurance products in 34 states, aiming to enhance the management of patients with polychronic conditions and ensure seamless transitions to dialysis and pre-emptive kidney transplants.

CareBridge Health

Series B in 2019
CareBridge is a technology and services provider based in Nashville, Tennessee, dedicated to improving the lives of individuals with physical, intellectual, or developmental disabilities who receive home and community-based services. Founded in 2009, the company specializes in assisting health plans and states by offering comprehensive solutions such as electronic visit verification, data aggregation, and 24/7 clinical support. CareBridge focuses on ensuring that Medicaid recipients, as well as those dually eligible for Medicare and Medicaid, receive the necessary services, equipment, and support to maintain their independence at home. By facilitating continuous communication between patients, their families, and caregivers, CareBridge enhances the quality of care and promotes a supportive environment for those they serve.

Monogram Health

Series A in 2019
Monogram Health, Inc. is a provider of kidney care services based in Nashville, Tennessee, specializing in the management of chronic kidney disease and end-stage renal disease. Established in 2019, the company employs an innovative in-home care delivery model that integrates evidence-based clinical services, including complex case and disease management, utilization management, and medication therapy management. Monogram Health focuses on improving patient outcomes and quality of life while reducing medical costs through predictive analysis and next-generation artificial intelligence algorithms. It collaborates with leading health plans and risk-bearing providers to deliver care across various insurance products in 34 states, aiming to enhance the management of patients with polychronic conditions and ensure seamless transitions to dialysis and pre-emptive kidney transplants.

Carta Healthcare

Carta Healthcare, Inc. is a technology company that specializes in developing a software-as-a-service platform aimed at improving hospital patient management. Founded in 2016 and headquartered in San Mateo, California, the company leverages data from existing IT systems to map the patient journey through hospitals. Its platform utilizes machine learning to identify similarities between current patients and past patients, allowing healthcare providers to personalize care based on individual needs. Additionally, it predicts potential bottlenecks, such as recovery bed shortages and cancellations, offering alerts that help hospitals optimize their operations. By combining artificial intelligence with human expertise, Carta Healthcare enhances the efficiency and quality of healthcare data management, ultimately aiming to provide a better experience for patients.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.